AVANIA/FACTORY-CRO-GROUP
Factory-CRO Group , a medical technology contract research organization (CRO) formed by the merger of BBA (Boston, U.S.), Factory CRO (Netherlands), Five Corners (Australia), and MileStone Research Organization (San Diego, U.S.), is pleased to announce its rebranding as Avania .
Avania brings knowledgeable experts together to form a unique CRO that advances the research of medical devices, novel technology, and combination products. The Avania team’s regional experience and global expertise starts with early strategic consulting that then guides your product from feasibility all the way through post-marketing.
“We recognize that the timing of a new brand launch during the COVID-19 pandemic is unusual. However, Avania has the unique advantage of having a global perspective in managing complex challenges, built on 30 years of experience,” said Sapna Hornyak , MBA, M.S., president and chief executive officer of Avania. “We have created a better kind of medtech CRO, one that is specialized and worldwide. Our motivated team is known for navigating medical technology to market effectively and efficiently, with expertise and integrity.”
The newly branded Avania will continue as one united global CRO, bringing together regional teams of experts across a wide range of therapeutic specialties.
About Avania
Avania is a leading, full-service contract research organization focused on the management of clinical studies for medical devices, IVDs, biologics, and device-drug combination products internationally. Avania supports products from the first-in-human phase through the post-market phase with the same customized approach. When you need to advance your medical technology, it takes Avania.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200324005602/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Uptime Announces Annual Outage Analysis Report 20256.5.2025 11:02:00 CEST | Press release
7th Annual Report analyzes data on IT and data center outages including causes, costs and consequences Uptime Institute today announced the release of its 7th Annual Outage Analysis 2025 keynote report. The prevention of data center outages continues to be a strategic priority for data center owners and operators. Infrastructure equipment has improved, but the complexity of modern architectures and evolving external threats presents new risks that operators must actively manage. For the fourth consecutive year, Uptime Intelligence Research suggests that overall outage frequency and the general level of reported severity continue to decline. However, cyber security incidents are on the rise and often have severe, lasting impacts. “Outages overall have slowed down,” said Andy Lawrence, founding member and executive director, Uptime Intelligence. “Data center operators are facing a growing number of external risks beyond their control, including power grid constraints, extreme weather, ne
Codethink Limited Announces World’s First Baseline Safety Assessment for a Linux-Based OS to SIL 3 / ASIL D6.5.2025 11:00:00 CEST | Press release
Codethink today announced the publication of its baseline Safety Assessment report for Codethink Trustable Reproducible Linux (CTRL OS). exida’s assessment validates Codethink’s safety argument for use of CTRL OS in safety-critical and mixed-criticality systems up to SIL 3 / ASIL D, and independently confirms that Codethink’s approach satisfies the expectations of both IEC 61508 and ISO 26262. This is the latest milestone in Codethink’s strategic journey to establish a defensible, engineering-led methodology for the use of Open Source software in systems where safety, security, performance, availability, and reliability are considered critical. “We are concentrating on the real work of engineering safety, security, and reliability, not just chasing certificates by following a standard,” said Paul Sherwood, Codethink’s Chairman. “This all boils down to trust. How can we trust software to do what we expect, and how can we trust our mitigations when things go wrong?” Codethink’s solution
Lineage Expands Nordic Presence with Strategic Acquisition of Permanor AS in Norway6.5.2025 09:00:00 CEST | Press release
Lineage completes acquisition of Permanor AS, strengthening its cold storage and logistics capabilities across Norway and the broader Nordic region. The operations and property in Haugesund and the operations in Brumunddal will enhance Lineage’s ability to serve the Nordic region’s meat and food industry, with a focus on sustainability and energy efficiency. Lineage, Inc. (NASDAQ: LINE) (“Lineage”), the world’s largest global temperature-controlled warehouse REIT, today announced that it has completed the acquisition of Permanor AS, a leading provider of cold storage and logistics solutions in Norway. The acquisition includes Permanor AS’s operations and property in Haugesund and Brumunddal, further strengthening Lineage’s footprint in the Nordics market and enhancing its ability to serve the region’s growing food supply chain. Permanor AS specializes in freezing, thawing, storage, and logistics services, primarily catering to the meat manufacturing industry, alongside handling baked g
Agendia to Present FLEX Study Data on Impact of BluePrint® at ESMO Breast Cancer 20256.5.2025 08:00:00 CEST | Press release
Real-world analysis shows BluePrint® identifies chemotherapy-sensitive Basal-type tumors among MammaPrint® High Risk HR+ HER2- breast cancers, supporting more personalized treatment strategies Agendia®, Inc., today announced that new data from its ongoing FLEX Study will be presented at the upcoming ESMO BreastCancer 2025 congress taking place May 14-17 in both Munich, Germany and virtually. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250505212759/en/ The FLEX Study (NCT03053193) is a prospective real-world evidence, observational breast cancer study designed to correlate whole transcriptome gene expression in early-stage breast cancer with clinical outcomes, and to evaluate how genomic insights can inform treatment decisions in early-stage breast cancer. In this analysis, researchers examined the impact of BluePrint, Agendia’s 80-gene molecular subtyping assay, on pathological complete response (pCR) rates and chemothera
Owkin Launches K Navigator, a Ground-breaking Agentic Co-pilot to Speed up Breakthroughs in Biomedical Research by 20x6.5.2025 06:15:00 CEST | Press release
K Navigator increases researcher productivity by 20x¹, accelerating biomedical breakthroughs and outperforming leading generalist LLMs Analyzes and visualizes multimodal patient data, plus exclusive access to MOSAIC Window, a subset of the world’s largest spatial omics dataset in oncology Built by biologists, for biologists. Free to use for academic researchers.² Owkin, a leading agentic AI company, has launched K Navigator, an AI-powered research co-pilot designed to revolutionize biomedical science. K Navigator is an agentic playground where researchers can explore, refine, and validate hypotheses, accelerating the quality and pace of their discoveries. With K Navigator, Owkin moves closer to its vision of developing the world’s first Biological Artificial Superintelligence (BASI). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250505282917/en/ K Navigator home screen. A single natural language interface - K Navigator enab
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom